Ricolinostat
| CAS No. | 1316214-52-4 |
|---|---|
| MDL No. | MFCD22666356 |
| MF | C24H27N5O3 |
| MW | 433.50 |
| InChI Key | QGZYDVAGYRLSKP-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Ricolinostat is a pyrimidine substituted with diphenylamino and [7-(hydroxyamino)-7-oxoheptyl]aminocarbonyl groups at positions 2 and 5, respectively. It is a histone deacetylase 6 inhibitor with potential antineoplastic activity. It functions as an EC 3.5.1.98 inhibitor, apoptosis inducer, antineoplastic agent, and anti-inflammatory agent. It is classified as a pyrimidinecarboxamide, secondary carboxamide, hydroxamic acid, substituted aniline, and tertiary amino compound.
| CAS No. | 1316214-52-4 |
|---|---|
| Product Name | Ricolinostat |
Biological Targets
HDAC6
Associated Conditions
multiple myeloma·chronic lymphocytic leukemia·diabetic neuropathy·breast carcinoma·lymphoid neoplasm·
* The information provided here is compiled from public sources and is for reference only.
